FGF23 and undifferentiated pleomorphic sarcoma: The exploration of other targets, such as Neurotensin Receptor 1 (NTSR1) and Fibroblast Growth Factor 23 (FGF23), continues to provide new insights into potential therapeutic strategies that could impede the aggressive behavior and proliferation of UPS cells [29,88].